Causes
The ÌÇÐÄ´«Ã½ Center for Memory Disorders is encouraged that there is another new treatment option for certain patients with Alzheimer’s disease.ÌýOur neurologists are preparing to begin prescribing Donanemab.
Before contacting your ÌÇÐÄ´«Ã½ neurologist to see whether Donanemab might be appropriate for you, please consider the safety information below. Many side effects will be like Lecanemab as noted inÌýthese FAQs.
Clinical Trials
Open trials refer to studies currently recruiting participants or that may recruit participants in the near future. Closed trials are not currently enrolling, but similar studies may open in the future.
Closed trials are not currently enrolling, but may open in the future.
Condition Spotlight
Our Clinics
See a Stanford specialist to learn about your treatment options. Visit one of our clinics to make an appointment.
